The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: a placebo-controlled randomised clinical trial.

@article{Grusovin2009TheEO,
  title={The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: a placebo-controlled randomised clinical trial.},
  author={Maria Gabriella Grusovin and Marco Esposito},
  journal={European journal of oral implantology},
  year={2009},
  volume={2 1},
  pages={43-54}
}
PURPOSE To evaluate the efficacy of Emdogain versus placebo (its carrier) for the treatment of deep infrabony defects. MATERIALS AND METHODS Thirty patients with an infrabony defect of at least 4 mm deep and at least 2 mm wide were randomly allocated for treatment with either Emdogain or placebo (the Emdogain carrier). The treating clinician was completely blinded to the therapy provided and performed all evaluations blindly up to the third year of follow-up. Outcome measures were tooth loss… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
6 Extracted Citations
0 Extracted References
Similar Papers

Similar Papers

Loading similar papers…